Search
for
Did you mean Targeted Therapies?
Sort by
Research 30 of 1000+
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous adverse effects of targeted therapies
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cancer-Related Alopecia: From Etiologies to Global Management
- Therapeutic and Diagnostic Applications of Nanotechnology in Dermatology and Cosmetics
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Management of Toxicities of Targeted Therapies
- Management of the adverse effects of targeted therapy for cancer
- Cutaneous adverse effects of targeted therapies
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- An in-depth study of DOPE:DOPC liposomes to maximize targeted drug delivery to cancer-associated cells
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Hair Changes due to Drugs
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Skin Manifestations of Targeted Antineoplastic Therapy
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital